Tag: Biotechnology

RFK Jr.’s vaccine panel defers vote on hepatitis B shot for babies until Friday

Posted on By Admin No Comments on RFK Jr.’s vaccine panel defers vote on hepatitis B shot for babies until Friday

Health and Human Services Secretary Robert F. Kennedy Jr.’s hand-picked vaccine committee on Thursday deferred crucial votes on hepatitis B vaccines for babies until Friday, saying it will give members more time to review proposed language on the measure. One panel member, Dr. Cody Meissner, a professor of pediatrics at the Dartmouth Geisel School of…

Read More “RFK Jr.’s vaccine panel defers vote on hepatitis B shot for babies until Friday” »

Health

Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

Posted on By Admin No Comments on Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it has cut the direct-to-consumer prices of its blockbuster weight loss drug Wegovy and diabetes counterpart Ozempic, adding to efforts by the company and the Trump administration to…

Read More “Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month” »

Health

CDC takes down more than a dozen webpages on sexual and gender identity, health equity

Posted on By Admin No Comments on CDC takes down more than a dozen webpages on sexual and gender identity, health equity

A sign for the CDC sits outside of their facility at the Centers for Disease Control and Prevention Roybal campus in Atlanta, Georgia, U.S., May 30, 2025. Megan Varner | Reuters More than a dozen pages on the Centers for Disease Control and Prevention website related to sexual and gender identity, health equity, and other…

Read More “CDC takes down more than a dozen webpages on sexual and gender identity, health equity” »

Health

Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors

Posted on By Admin No Comments on Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly‘s stock is still recovering after the drugmaker released trial data earlier this month on its closely watched obesity pill that underwhelmed Wall Street. In a key late-stage trial,…

Read More “Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors” »

Health

Weight loss drugs could be a gamechanger for women with a common hormonal disorder

Posted on By Admin No Comments on Weight loss drugs could be a gamechanger for women with a common hormonal disorder

Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images For well over a decade, Grace Hamilton, 27, experienced hair loss, heavy periods, infrequent menstrual cycles, mental health issues and difficulty losing weight without knowing why. It wasn’t until 2023 when she was diagnosed with…

Read More “Weight loss drugs could be a gamechanger for women with a common hormonal disorder” »

Health

Medicaid cuts in Trump’s ‘big beautiful bill’ will leave millions uninsured, threaten rural hospitals

Posted on By Admin No Comments on Medicaid cuts in Trump’s ‘big beautiful bill’ will leave millions uninsured, threaten rural hospitals

An aerial view of Valley Health Hampshire Memorial Hospital on June 17, 2025 in Romney, W.V. Ricky Carioti | The Washington Post | Getty Images President Donald Trump‘s “big beautiful bill” would make sweeping changes to U.S. health care, leaving millions of vulnerable Americans without health insurance and threatening the hospitals and centers that provide…

Read More “Medicaid cuts in Trump’s ‘big beautiful bill’ will leave millions uninsured, threaten rural hospitals” »

Health

Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know 

Posted on By Admin No Comments on Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know 

President Donald Trump, joined by National Institutes of Health (NIH) Director Jay Bhattacharya, speaks during a press conference in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images News | Getty Images President Donald Trump on Monday moved forward with a plan to lower U.S….

Read More “Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know ” »

Health

Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

Posted on By Admin No Comments on Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk.  Reuters President Donald Trump on Friday dropped a Biden administration proposal to have Medicare cover obesity drugs, including popular but costly GLP-1 treatments such as Novo Nordisk‘s Wegovy and Eli Lilly‘s Zepbound. But the Centers…

Read More “Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound” »

Health

UnitedHealth Group CEO addresses Brian Thompson death, says health-care system is ‘flawed’

Posted on By Admin No Comments on UnitedHealth Group CEO addresses Brian Thompson death, says health-care system is ‘flawed’

Andrew Witty, CEO of UnitedHealth Group, testifies during the Senate Finance Committee hearing titled “Hacking America’s Health Care: Assessing the Change Healthcare Cyber Attack and What’s Next,” in the Dirksen Building in Washington, D.C., on May 1, 2024. Tom Williams | Cq-roll Call, Inc. | Getty Images UnitedHealth Group CEO Andrew Witty on Friday mourned…

Read More “UnitedHealth Group CEO addresses Brian Thompson death, says health-care system is ‘flawed’” »

Health

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

Posted on By Admin No Comments on Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images Amgen on Tuesday said its experimental weight loss injection helped patients with obesity lose up to 20% of their weight on average after a year in a critical mid-stage trial, as the company races…

Read More “Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau” »

Health